Arterial stiffness and endothelial function in obstructive sleep apnoea: the effect of Continuous Positive Airway Pressure (CPAP) therapy
dc.contributor.advisor
Riha, Renata
en
dc.contributor.author
Jones, Anne
en
dc.contributor.sponsor
other
en
dc.date.accessioned
2017-11-02T14:30:16Z
dc.date.available
2017-11-02T14:30:16Z
dc.date.issued
2016-11-29
dc.description.abstract
Introduction: Obstructive sleep apnoea (OSA) is common and is caused by
repetitive obstruction of the upper airway during sleep. OSA is associated with
increased cardiovascular morbidity and mortality and is an independent risk factor
for hypertension. The immediate physiological effects of OSA include intermittent
hypoxia, repeated arousal from sleep and intra-thoracic pressure swings. The
resulting activation of the sympathetic nervous system, systemic inflammation and
oxidative stress may result in increased arterial stiffness and endothelial dysfunction,
potentially explaining any causal link between OSA and cardiovascular disease
(CVD). Continuous positive airway pressure (CPAP) therapy improves excessive
daytime sleepiness (EDS) and in non-randomised studies, reduces cardiovascular
mortality. Prior to starting this study, there was a limited amount of evidence
suggesting that CPAP therapy improved arterial stiffness and endothelial function,
but the effects in subjects without pre-existing CVD were unclear.
Aims: i) to determine whether CPAP therapy has an effect upon measures of arterial
stiffness and endothelial function in patients with OSA, in the absence of known
CVD. ii) To compare arterial stiffness and endothelial function in a subset of patients
with OSAHS (defined as OSA and EDS), with a group of well-matched control
subjects.
Methods: Fifty three patients with OSA, defined as an apnoea/hypopnoea index of
≥15, and without known CVD, entered a double-blind placebo-controlled crossover
trial of 12 weeks CPAP therapy, of whom forty three completed the study protocol.
Sham CPAP was used in the placebo arm of the study and vascular assessments were
made at baseline and after each arm of the study. Arterial stiffness was determined
by measuring aortic distensibility using cardiovascular magnetic resonance imaging
and by measuring the augmentation index (AIx) and aortic pulse wave velocity
(PWV) by applanation tonometry. Endothelial function was assessed non-invasively
by measuring vascular reactivity after administration of salbutamol and glyceryl
trinitrate. In a subset of twenty patients with OSAHS, arterial stiffness and
endothelial function at baseline were compared to readings obtained from healthy
control subjects, matched on a one-to-one basis for age, sex and BMI.
Results: Patients with OSAHS (n=20) had increased arterial stiffness [AIx
19.3(10.9) vs. 12.6(10.2) %; p=0.017] and impaired endothelial function, measured
as the change in AIx following salbutamol [-4.3(3.2) vs. -8.0(4.9) %; p=0.02]
compared to controls. Twelve weeks of CPAP therapy had no significant effect upon
any measure of arterial stiffness or endothelial function in patients with OSA (n=43).
A trend towards a reduction in AIx following CPAP therapy was seen, but this was
non-significant. There was a reduction in systolic blood pressure following CPAP
therapy [126(12) vs. 129(14) mmHg]. Sub group analysis showed CPAP to have no
effect on arterial stiffness or endothelial function in patients with EDS or in patients
using CPAP for ≥4 hours per night.
Conclusions: This study demonstrates that even in the absence of known CVD,
patients with OSAHS have evidence of increased arterial stiffness and impaired
endothelial function. However, in patients with OSA, free from CVD, CPAP therapy
did not lead to an improvement in any measure of arterial stiffness or endothelial
function after 12 weeks.
en
dc.identifier.uri
http://hdl.handle.net/1842/25391
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Jones A, Vennelle M, Connell M, McKillop G, Newby DE, Douglas NJ, Riha RL. Arterial stiffness and endothelial function in obstructive sleep apnoea/hypopnoea syndrome. Sleep Med 2013;14(5):428-432
en
dc.relation.hasversion
Jones A, Vennelle M, Connell M, McKillop G, Newby DE, Douglas NJ, Riha RL. The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease. Sleep Med 2013;14(12):1260-1265
en
dc.subject
obstructive sleep apnoea/hypopnoea syndrome
en
dc.subject
cardiovascular disease
en
dc.subject
arterial stiffness
en
dc.subject
endothelial dysfunction
en
dc.subject
continuous positive airway pressure
en
dc.subject
CPAP
en
dc.title
Arterial stiffness and endothelial function in obstructive sleep apnoea: the effect of Continuous Positive Airway Pressure (CPAP) therapy
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Jones2016.pdf
- Size:
- 3.56 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

